What is Inogen's stock issuance proceeds?

Inogen (INGN) reported stock issuance proceeds of $27.21M in Q1 2025.

What does stock issuance proceeds mean?

Represents the total cash inflows from the issuance of common equity to investors or through public offerings. This is a primary indicator of the company's ability to raise external capital to fund operations, debt repayment, or strategic initiatives.

Inogen INGN Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

ResMedRMD

——

Other financials

Income statement

See full

Revenue$85.1M+3.4%

Gross profit$44.9M+1.7%

Operating income-$9.3M-21.9%

Net income-$8.3M-34.8%

EPS (diluted)-$0.30-20.0%

Balance sheet

See full

Cash & equivalents$93.1M-21.7%

Total debt$16.9M-11.9%

Total equity$182.9M-7.6%

Total assets$285.9M-7.3%

Cash flow

See full

Operating cash flow-$6.7M+60.2%

CapEx$210.0K-28.1%

Free cash flow-$6.9M+59.6%

Valuation

See full

Market cap$174.63M-9.7%

Enterprise value$98.45M-9.5%

P/S0.5×-0.1×

Profitability

See full

Gross margin52.8%-2.6pp

Operating margin-9.1%-0.8pp

Net margin-7.1%-0.8pp

FCF margin0.4%—

Returns & leverage

See full

Return on equity-13.1%-0.9pp

Debt / equity0.1×0.0×

Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Inogen’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inogen's stock issuance proceeds?: Inogen (INGN) reported stock issuance proceeds of $27.21M in Q1 2025.
What does stock issuance proceeds mean?: Represents the total cash inflows from the issuance of common equity to investors or through public offerings. This is a primary indicator of the company's ability to raise external capital to fund operations, debt repayment, or strategic initiatives.